Site icon Green Health Revolution

Infection with COVID-19 does not increase blood pressure in patients with chronic kidney disease

Infection with COVID-19 does not increase blood pressure in patients with chronic kidney disease
  • Thakkar J, Chand S, Aboodi MS, Gone AR, Alahiri E, Schecter DE, et al. Characteristics, outcomes and 60-Day hospital mortality of ICU patients with COVID-19 and acute kidney injury. Kidney360. 2020;1:1339–44.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–81.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–90.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–4.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, et al. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int. 2005;68:2189–96.

    Article 
    PubMed 

    Google Scholar 

  • South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020;16:305–7.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, et al. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31:e2176.

    Article 
    PubMed 

    Google Scholar 

  • Kamalumpundi V, Kawasaki S, Cheng L, Meyers EE, Shams E, Ofori O, et al. Association between renin-angiotensin antagonism and COVID-19-related mortality in patients with essential hypertension: A single center, retrospective cohort study. J Clin Hypertens (Greenwich). 2024;26:1039–44.

    Article 
    PubMed 

    Google Scholar 

  • Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583–90.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Petersen EL, Gossling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur Heart J. 2022;43:1124–37.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899–911.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zuin M, Rigatelli G, Bilato C, Pasquetto G, Mazza A. Risk of incident new-onset arterial hypertension after COVID-19 recovery: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2023;30:227–33.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Delalic D, Jug J, Prkacin I. Arterial Hypertension Following Covid-19: a retrospective study of patients in a Central European Tertiary care center. Acta Clin Croat. 2022;61:23–7.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang V, Fisher M, Hou W, Zhang L, Duong TQ. Incidence of new-onset hypertension Post-COVID-19: comparison with influenza. Hypertension. 2023;80:2135–48.

    Article 
    PubMed 

    Google Scholar 

  • Georgianos PI, Agarwal R. Hypertension in chronic kidney disease-treatment standard 2023. Nephrol Dial Transplant. 2023;38:2694–703.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Trimarco V, Izzo R, Pacella D, Trama U, Manzi MV, Lombardi A, et al. Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population. BMC Med. 2024;22:127.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gotanda H, Liyanage-Don N, Moran AE, Krousel-Wood M, Green JB, Zhang Y, et al. Changes in blood pressure outcomes among hypertensive individuals during the COVID-19 Pandemic: a time series analysis in three US healthcare organizations. Hypertension. 2022;79:2733–42.

    Article 
    PubMed 

    Google Scholar 

  • Wojciechowska W, Rajzer M, Kreutz R, Weber T, Bursztyn M, Persu A, et al. The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study). J Hypertens. 2024;42:2065–74.

    Article 
    PubMed 

    Google Scholar 

  • Schmidt-Lauber C, Alba Schmidt E, Hanzelmann S, Petersen EL, Behrendt CA, Twerenbold R, et al. Increased blood pressure after nonsevere COVID-19. J Hypertens. 2023;41:1721–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Bar-Or I, Indenbaum V, Weil M, Elul M, Levi N, Aguvaev I, et al. National scale real-time surveillance of SARS-CoV-2 variants dynamics by wastewater monitoring in Israel. Viruses. 2022;14:1229.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29:334–43.

    Article 
    PubMed 

    Google Scholar 

  • Force USPST, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, et al. Screening for hypertension in adults: US Preventive Services task force reaffirmation recommendation statement. JAMA. 2021;325:1650–6.

    Article 

    Google Scholar 

  • Kim R, Nachman S, Fernandes R, Meyers K, Taylor M, LeBlanc D, et al. Comparison of COVID-19 infections among healthcare workers and non-healthcare workers. PLoS One. 2020;15:e0241956.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Stepanova M, Lam B, Younossi E, Felix S, Ziayee M, Price J, et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis. 2022;22:702.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Paiva AMG, Gomes M, Campana EMG, Feitosa ADM, Sposito AC, Mota-Gomes MA, et al. Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use. Hypertens Res. 2019;42:1989–95.

    Article 
    PubMed 

    Google Scholar 

  • link

    Exit mobile version